HDF

FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA

Retrieved on: 
Thursday, April 4, 2024
Diabetes, Fibroblast, EGFR, Warfarin necrosis, Risk, Communication, IL-6, Form, Diabetic foot ulcer, Conditional sentence, Patient, Research, Mouse, Gamma ray, Trial of the century, HDF, Hyperglycemia, Acceleration, Wound healing, Cytokine, Therapy, Cellular senescence, Interleukin, VEGF, Pharmaceutical industry

These findings will be presented via an oral and poster presentation at the Advanced Wound Care Summit USA in Boston, MA, April 16-17.

Key Points: 
  • These findings will be presented via an oral and poster presentation at the Advanced Wound Care Summit USA in Boston, MA, April 16-17.
  • Diabetic foot ulcers (DFUs) are prevalent in individuals with diabetes, with approximately 33 million people impacted globally.
  • FibroBiologics' research aims to address this issue by investigating the potential of using human dermal fibroblast (HDF) spheroids in promoting and accelerating the wound healing process in diabetic patients.
  • "These results support the potential of HDF spheroids to expedite the healing process of chronic wounds associated with diabetes," said Dr. Khoja.

Ricoh announces GR series cameras featuring built-in highlight diffusion filter

Retrieved on: 
Wednesday, March 27, 2024
DSLR, PENTAX, Ricoh, SLR, Name, RICOH, HDF, Lens, Multimedia, Camera

PARSIPPANY, N.J., March 27, 2024 /PRNewswire/ -- Ricoh Imaging Americas Corporation today announced the RICOH GR III HDF and RICOH GR IIIx HDF premium digital compact cameras. These new versions of the acclaimed RICOH GR III and RICOH GR IIIx cameras feature a newly-developed Highlight Diffusion Filter (HDF) that diffuses highlights for softer light, creating more expressive images with a sense of depth and emotion. The HDF, which can be turned on and off in a single action, allows the user to add a totally different kind of visual expression to captured images.

Key Points: 
  • PARSIPPANY, N.J., March 27, 2024 /PRNewswire/ -- Ricoh Imaging Americas Corporation today announced the RICOH GR III HDF and RICOH GR IIIx HDF premium digital compact cameras.
  • These new versions of the acclaimed RICOH GR III and RICOH GR IIIx cameras feature a newly-developed Highlight Diffusion Filter (HDF) that diffuses highlights for softer light, creating more expressive images with a sense of depth and emotion.
  • "The RICOH GR III HDF and RICOH GR IIIx HDF inherit the fundamental merits of our GR series – exceptional image quality, flawless point-and-shoot operation and outstanding portability," said Ken Curry, president, Ricoh Imaging Americas Corporation.
  • The RICOH GR III HDF and RICOH GR IIIx HDF will be available in April at www.us.ricoh-imaging.com as well as at Ricoh Imaging-authorized retail outlets at a manufacturer's suggested retail price of $1,069.95 for the RICOH GR III HDF and $1,149.95 for the RICOH GR IIIx HDF.

Northann Corp.’s New 3-D Printing Ecosystem Products Receive “Best of” Innovation Awards at TISE2024

Retrieved on: 
Tuesday, January 30, 2024
HDF, ELK, Sustainability, Award, Ecosystem, Wood, NCL, Artificial intelligence

TISE, the largest North American exposition for the floor covering, stone, and tile industry that concluded January 26th in Las Vegas, featured over 2,000 exhibitors from around the globe.

Key Points: 
  • TISE, the largest North American exposition for the floor covering, stone, and tile industry that concluded January 26th in Las Vegas, featured over 2,000 exhibitors from around the globe.
  • Cited in the award were four new product additions to Northann’s Benchwick brand 3D-printing ecosystem, each developed with advanced design features integrating recycled materials and sustainable manufacturing processes.
  • "We are thrilled to have received these awards for our 3D-printed innovations at TISE 2024," said Northann CEO, Mr. Lin Li.
  • Award at TISE Displayed at NCL Booth Source: Northann Corp.

Northann Corp Announces Benchwick Product and Technology Offerings for 2024 International Surface Event in Las Vegas

Retrieved on: 
Monday, January 22, 2024
Wall, NCL, Wood, Mandalay Bay Convention Center, Artificial intelligence, Envision, Ecosystem, Exhibit, ELK, 3D, HDF, 3D printing

Featured in this lineup will be Northann’s latest Benchwick brand 3D-printing ecosystem offerings equipped with advanced design features integrating recycled materials and sustainable manufacturing processes.

Key Points: 
  • Featured in this lineup will be Northann’s latest Benchwick brand 3D-printing ecosystem offerings equipped with advanced design features integrating recycled materials and sustainable manufacturing processes.
  • Updated AI-Powered Envision Engine: Benchwick is proud to introduce version 0.5 of our Artificial Intelligence image creation tool, the Envision Engine.
  • "We are thrilled to unveil these exciting innovations at TISE 2024," said Lin Li, Northann CEO.
  • “These groundbreaking advancements in our Benchwick 3D printing ecosystem underscore our commitment to innovation, sustainability, and versatility.

Global Engineered Wood Industry Report 2023: Burgeoning Opportunities in Modular Construction, Bio-based Adhesives, and Innovative Applications - ResearchAndMarkets.com

Retrieved on: 
Monday, December 4, 2023
Packaging, Chemicals, Plastics, Forest Products, Manufacturing, Natural Resources, Other Manufacturing, Building material, MUF, EW, CLT, MDI, MDF, HDF, Growth, LVL, OSB, Formaldehyde, Renewable energy, Engineered wood

The "Global Engineered Wood Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Engineered Wood Growth Opportunities" report has been added to ResearchAndMarkets.com's offering.
  • By application, EW volumes are segmented into construction, joinery (furniture, cabinetry, moldings, shelves), packaging, and others (nautical uses, equipment for trains, wooden toys).
  • Prices have suffered great volatility in the last few years and are expected to keep rising in the near future.
  • In terms of growth opportunities, the analysis shows that mass timber will keep growing in the construction sector, and high-performance adhesives for these applications will follow.

Launch of the Groundbreaking Green Hydrogen Giga Project White Dunes in Morocco

Retrieved on: 
Friday, November 17, 2023
Environment, Finance, Other Energy, Utilities, Professional Services, Alternative Energy, Sustainability, Green Technology, Energy, USD, HDF, Wind, Hydrogen, Area studies, Heart, Renewable energy

In line with Moroccan authorities' objectives, Falcon Capital Dakhla proudly reveals a strategic collaboration with HDF Energy, an industry leader in green hydrogen, to produce some of the world's cheapest green hydrogen.

Key Points: 
  • In line with Moroccan authorities' objectives, Falcon Capital Dakhla proudly reveals a strategic collaboration with HDF Energy, an industry leader in green hydrogen, to produce some of the world's cheapest green hydrogen.
  • The White Dunes project, spearheaded by Moroccan enterprise Falcon Capital Dakhla, aims to forge a strategic alliance with HDF ENERGY (mnemonic code: HDF) for the establishment of a green hydrogen production facility in the heart of the Dakhla region.
  • Majid Slimani, the founder and president of Falcon Capital Dakhla, underscores the significance of White Dunes in the context of Morocco's green hydrogen landscape.
  • Slimani states, "White Dunes embodies a commitment to the cause of green energy and a dedication to more sustainable future for Morocco.

Nephros Announces Results for Quarter Ended September 30, 2023

Retrieved on: 
Wednesday, November 8, 2023
Adjustment, Research, HDF, Kidney, EBITDA, Filtration, Quarter, GAAP, Infection, Growth, Dialysis, Depreciation, Video game, Rare-earth element, Tourism, Pharmaceutical industry, Bookkeeping, Cryptocurrency

SOUTH ORANGE, NJ, Nov. 08, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2023.

Key Points: 
  • Net loss from continuing operations for the quarter ended September 30, 2023, was $0.2 million, compared with $1.3 million during the same period in 2022.
  • Adjusted EBITDA from continuing operations for the quarter ended September 30, 2023, was $11,000, compared with ($0.3 million) during the same period in 2022.
  • Gross margin for the quarter ended September 30, 2023 was 59%, compared with 32% during the same period in 2022.
  • Research and development expenses for the quarter ended September 30, 2023, were $0.2 million, compared with $0.3 million during the quarter ended September 30, 2022.

Baxter Highlights New Data at Kidney Week Indicating Sharesource Is Associated With a 77% Lower Risk of Home Dialysis Technique Failure

Retrieved on: 
Monday, November 6, 2023
Health, Hospitals, Surgery, Health Technology, Practice Management, General Health, Water, RPM, MB, PD, NYSE, Health care, HDF, APD, HD, In re Caremark International Inc. Derivative Litigation, Infection, Peritoneal dialysis, Electricity, Kidney, Research, Inflammation, Hemofiltration, Dialysis, ASN, Risk, HDX, Blood, Hospital, Patient, Bed, Baxter International, Failure, Cardiovascular disease, Medical device, Pharmaceutical industry

Technique failure can be due to several factors and results in PD patients being switched to in-center dialysis.

Key Points: 
  • Technique failure can be due to several factors and results in PD patients being switched to in-center dialysis.
  • In propensity matched patients, the use of Sharesource was associated with a 77% reduction in risk of technique failure (HR 0.23 95% CI 0.06-0.83, p = 0.024).
  • Water consumption per year with online HDF was 4.1 million liters, but consumption was 27% lower with the use of HDx therapy.
  • Furthermore, data indicate HDx therapy demonstrated 17% lower electricity and associated costs.

Fresenius Medical Care Demonstrates Commitment to Innovating Dialysis and Kidney Disease Care with Presentations at the American Society of Nephrology (ASN) Kidney Week 2023

Retrieved on: 
Tuesday, October 31, 2023
Kidney, Frankfurt Stock Exchange, Patient, Hemofiltration, Research, FME, Intelligence, III, HDF, Assessment of kidney function, AVF, Big data, Fatigue, HD, American Society of Nephrology, Saskatchewan River Sturgeon Management Board, Arteriovenous fistula, FX, Health, Society, Artificial intelligence, Dialysis, PO4, PSM, COVID-19, ASN, Machine learning, Congress, Fresenius Medical Care, FKC, RBV, Creatinine, Scientific Committee on Oceanic Research, FMS, Peritoneum, IDS, Data science, Pharmaceutical industry, Medical device, Hemodialysis, Nephrology

Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.

Key Points: 
  • Fresenius Medical Care announces presentations at the American Society of Nephrology (ASN) Kidney Week 2023.
  • Scientific and medical experts from across Fresenius Medical Care will present research related to many important topics in kidney disease care.
  • Through its network of 4,050 dialysis clinics, Fresenius Medical Care provides dialysis treatments for approximately 344,000 patients around the globe.
  • Fresenius Medical Care AG & Co. KGaA does not undertake any responsibility to update the forward-looking statements in this release.

Hereditary Disease Foundation Announces Recipients of Inaugural Transformative Research Award

Retrieved on: 
Wednesday, October 4, 2023
DSM-IV codes, HD, CRISPR, Partnership, Broad Institute, University, Hereditary Disease Foundation, HDF, Therapy, PIAS1, University of California, Irvine Medical Center, Breeding, Gene editing, DRS, MBA, Research, Brain, MIT, AAV, Doctor of Philosophy, Harvard University, Harvard Medical School, Jackson, CAG, Protein, MSH3, Thompson, Transformative research, Mouse, Hospital, Somatic, Massachusetts General Hospital, Gene, Nursing, Medical device, MD

Dr. Davidson’s and Dr. Mouro Pinto’s teams each use cutting-edge methods but take different approaches to advance Huntington’s disease research that, if successful, could lead to truly transformative therapies for Huntington’s disease.

Key Points: 
  • Dr. Davidson’s and Dr. Mouro Pinto’s teams each use cutting-edge methods but take different approaches to advance Huntington’s disease research that, if successful, could lead to truly transformative therapies for Huntington’s disease.
  • The Transformative Research Awards were made possible through a partnership between the Hereditary Disease Foundation and a generous group of anonymous donors.
  • “These new awards are designed to move the most innovative work in Huntington’s disease from concept to practice,” said Meghan Donaldson, CEO of the Hereditary Disease Foundation.
  • “We are funding collaborative research teams who are focused on creating new ways to move toward a disease-modifying treatment and provide transformational new insights to the Huntington’s disease research field.